PCSK9i Reduces Plaque Burden in Coronary Arteries
Cardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM
Updates in the New AHA/ACC/HFSA Heart Failure Guideline
Treatment of Chronic Hypertension Reduces Adverse Pregnancy Outcomes
Impact of New First-in-Class Medical Therapy in Obstructive HCM
Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
Reduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
Study with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
Beginning of an Era: Treatment of Elevated Lp(a)
Novel Form of CV Research with Dietary Education in the Grocery Store
Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
Breaking Down the Criteria for Iron Deficiency in Heart Failure
Javed Butler, MD
John Cleland
Fraser Graham, MD
Challenging the Theory That Light Alcohol Consumption Benefits Heart Health
Dissecting Disparities in Cardiogenic Shock Treatment & Survival
Reviewing the Role of SGLT2 Inhibitors in Heart Failure
Mikhail Kosiborod, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.